非凡領越(00933.HK):由GEM轉往主板上市 預計6月27日起在主板買賣
格隆匯6月20日丨非凡領越(00933.HK)發佈公吿,聯交所已於2023年6月19日原則上批准轉板上市。公司已於2023年6月20日就轉板上市刊發上市文件。
股份於GEM(GEM股份代號:8032)買賣的最後交易日將為2023年6月26日。預期股份將於2023年6月27日上午九時正開始在主板(主板股份代號:933)買賣。公司的中英文股票簡稱、現有股份股票、每手買賣單位、買賣貨幣、主要股份過户登記處及香港股份過户登記分處於緊隨轉板上市後將保持不變。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.